Skip to main content
SpringerLink
Log in

Sex and Gender Differences in Neurology

  • Chapter
  • First Online:
Sex and Gender Aspects in Clinical Medicine

Abstract

Neurology deals with disorders of the nervous system that may involve its central, peripheral, and/or autonomic part and its effector tissue (particularly muscle). Sex and gender affects the incidence, prevalence, and dynamics of central nervous system (CNS) diseases. This chapter deals with examples of gender differences in neurological diseases and describes a broad variety of underlying pathologies. The examples given include nervous diseases of inflammatory (multiple sclerosis), vascular (stroke), and degenerative (Alzheimer’s and Parkinson’s) origin, as well as a functional state of increased vulnerability to seizures (Epilepsy) (Fig. 11.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rooney WD, Coyle PK. Recent advances in the neuroimaging of multiple sclerosis. Curr Neurol Neurosci Rep. 2005; 5:217-224.

    PubMed  Google Scholar 

  2. Galanopoulou AS. GABA receptors as broadcasters of sexually differentiating signals in the brain. Epilepsia. 2005;46: 107-112.

    PubMed  CAS  Google Scholar 

  3. Watzka M, Bidlingmaier F, Schramm J, Klingmuller D, Stoffel-Wagner B. Sex- and age-specific differences in human brain CYP11A1 mRNA expression. J Neuroendocrinol. 1999;11:901-905.

    PubMed  CAS  Google Scholar 

  4. Kurtz J, Wiesner A, Götz P, Sauer KP. Gender differences and individual variation in the immune system of the scorpionfly Panorpa vulgaris (Insecta: Mecoptera). Dev Comp Immunol. 2000;24:1-12.

    PubMed  CAS  Google Scholar 

  5. Da Silva JA. Sex hormones and glucocorticoids: interactions with the immune system. Ann N Y Acad Sci. 1999;876:102-118.

    PubMed  Google Scholar 

  6. Rejdak K, Jackson S, Giovannoni G. Multiple sclerosis: a practical overview for clinicians. Br Med Bull. 2010;95:79-104.

    PubMed  Google Scholar 

  7. Sellner J, Kraus J, Awad A, Milo R, Hemmer B, Stüve O. The increasing incidence and prevalence of female multiple sclerosis – a critical analysis of potential environmental factors. Autoimmun Rev. 2011;10(8):495-502. Epub 2011 Feb 24.

    PubMed  Google Scholar 

  8. Alonso A, Jick SS, Olek MJ, Hernan MA. Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort. J Neurol. 2007;254:1736-1741.

    PubMed  CAS  Google Scholar 

  9. Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 2008; 71:129-135.

    PubMed  Google Scholar 

  10. Ness JM, Chabas D, Sadovnick AD, et al. Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007;68:S37-S45.

    PubMed  CAS  Google Scholar 

  11. Steinman L. Autoimmune disease. Sci Am. 1993;269:106-114.

    PubMed  CAS  Google Scholar 

  12. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol. 1997;158:446-451.

    PubMed  CAS  Google Scholar 

  13. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol. 2000;111:77-85.

    PubMed  CAS  Google Scholar 

  14. Schwendimann RN, Alekseeva N. Gender issues in multiple sclerosis. Int Rev Neurobiol. 2007;79:377-392.

    PubMed  Google Scholar 

  15. Kim S, Voskuhl RR. Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol. 1999;162:5561-5568.

    PubMed  CAS  Google Scholar 

  16. Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol. 2004;146:144-152.

    PubMed  CAS  Google Scholar 

  17. Kuhlmann T, Goldschmidt T, Antel J, et al. Gender differences in the histopathology of MS? J Neurol Sci. 2009;15(286):86-91.

    Google Scholar 

  18. van Walderveen MA et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol. 2001;58:76-81.

    PubMed  Google Scholar 

  19. Antulov R et al. Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Mult Scler. 2009;15:345-354.

    PubMed  CAS  Google Scholar 

  20. Fazekas F, Enzinger C, Wallner-Blazek M, Ropele S, Pluta-Fuerst A, Fuchs S. Gender differences in MRI studies on multiple sclerosis. J Neurol Sci. 2009;286:28-30.

    PubMed  Google Scholar 

  21. Shibasaki H, Kuroiwa Y. Sex difference of multiple sclerosis in Japan. Neurology. 1976;26:821-824.

    PubMed  CAS  Google Scholar 

  22. Vein AM, Voznesenskaia TG, Khromova LG. The course of disseminated sclerosis in men and women. Zh Nevrol Psikhiatr Im S S Korsakova. 1995;95:43-44.

    PubMed  CAS  Google Scholar 

  23. Tomassini V, Onesti E, Mainero C, et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry. 2005;76:272-275.

    PubMed  CAS  Google Scholar 

  24. Bever CT Jr, McFarlin DE, Levy HB. A comparison of interferon responses to poly ICLC in males and females. J Interferon Res. 1985;5:423-428.

    PubMed  CAS  Google Scholar 

  25. Bever CT Jr, McFarland HF, McFarlin DE, Levy HB. The kinetics of interferon induction by poly ICLC in humans. J Interferon Res. 1988;8:419-425.

    PubMed  CAS  Google Scholar 

  26. Gulick EE. Social support among persons with multiple sclerosis. Res Nurs Health. 1994;17:195-206.

    PubMed  CAS  Google Scholar 

  27. Good DM, Bower DA, Einsporn RL. Social support: gender differences in multiple sclerosis spousal caregivers. J Neurosci Nurs. 1995;27:305-311.

    PubMed  CAS  Google Scholar 

  28. Steck B, Amsler F, Kappos L, Burgin D. Gender-specific differences in the process of coping in families with a parent affected by a chronic somatic disease (e.g. multiple sclerosis). Psychopathology. 2001;34:236-244.

    PubMed  CAS  Google Scholar 

  29. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med. 1998;339:285-291.

    PubMed  CAS  Google Scholar 

  30. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain. 1995;118:253-261.

    PubMed  Google Scholar 

  31. Coyle PK, Johnson K, Stark Y, Pardo L. Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). J Neurol Neurosurg Psychiatry. 2003;74:443.

    Google Scholar 

  32. Bielekova B, Martin R. Development of biomarkers in multiple sclerosis. Brain. 2004;127:1463-1478.

    PubMed  Google Scholar 

  33. Beatty WW, Aupperle RL. Sex differences in cognitive impairment in multiple sclerosis. Clin Neuropsychol. 2002;16:472-480.

    PubMed  Google Scholar 

  34. Fraser C, Polito S. A comparative study of self-efficacy in men and women with multiple sclerosis. J Neurosci Nurs. 2007;39:102-106.

    PubMed  Google Scholar 

  35. Di Carlo A, Lamassa M, Baldereschi M, et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke. 2003;34:1114-1119.

    PubMed  Google Scholar 

  36. Carandang R, Seshadri S, Beiser A, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296:2939-2946.

    PubMed  CAS  Google Scholar 

  37. Howard VJ, Cushman M, Pulley L, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25:135-143.

    PubMed  Google Scholar 

  38. Niewada M, Kobayashi A, Sandercock PA, Kamiński B, Członkowska A, International Stroke Trial Collaborative Group. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology. 2005;24:123-128.

    PubMed  Google Scholar 

  39. Benatru I, Rouaud O, Durier J, et al. Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke. 2006;37:1674-1679.

    PubMed  Google Scholar 

  40. Sheikh K, Bullock CM. Effect of measurement on sex difference in stroke mortality. Stroke. 2007;38:1085-1087.

    PubMed  Google Scholar 

  41. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995;26:361-367.

    PubMed  CAS  Google Scholar 

  42. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA. 2000;284:72-78.

    PubMed  CAS  Google Scholar 

  43. Lai SM, Duncan PW, Dew P, Keighley J. Sex differences in stroke recovery. Prev Chronic Dis. 2005;2:A13.

    PubMed  Google Scholar 

  44. Barrett KM et al. Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis. 2007;16:34-39.

    PubMed  Google Scholar 

  45. Reid JM et al. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke. 2008;39:1090-1095.

    PubMed  Google Scholar 

  46. Brown DL, Lisabeth LD, Garcia NM, Smith MA, Morgenstern LB. Emergency department evaluation of ischemic stroke and TIA: the BASIC Project. Neurology. 2004;63:2250-2254.

    PubMed  CAS  Google Scholar 

  47. Reed SD, Blough DK, Meyer K, Jarvik JG. Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. Neurology. 2001;57:305-314.

    PubMed  CAS  Google Scholar 

  48. Foerch C, Misselwitz B, Humpich M, et al. Sex disparity in the access of elderly patients to acute stroke care. Stroke. 2007;38:2123-2126.

    PubMed  Google Scholar 

  49. Glader EL et al. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003;34:1970-1975.

    PubMed  Google Scholar 

  50. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke. 2003;34:1581-1585.

    PubMed  Google Scholar 

  51. del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23:879-894.

    PubMed  Google Scholar 

  52. Gray LJ et al. Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke. 2007;38:2960-2964.

    PubMed  Google Scholar 

  53. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998;158:1133-1138.

    PubMed  CAS  Google Scholar 

  54. Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP. The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke. 1998;29:618-624.

    PubMed  CAS  Google Scholar 

  55. Eriksson M, Asplund K, Glader EL, et al. Self-reported depression and use of antidepressants after stroke: a national survey. Stroke. 2004;35:936-941.

    PubMed  Google Scholar 

  56. Kelly-Hayes M, Beiser A, Kase C, Scaramucci A, D’Agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis. 2003;12:119-126.

    PubMed  Google Scholar 

  57. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke. 2000;31:1833-1837.

    PubMed  CAS  Google Scholar 

  58. Theodore WH, Spencer SS, Wiebe S, et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia. 2006;47:1700-1722.

    PubMed  Google Scholar 

  59. Christensen J, Vestergaard M, Pedersen MG, Pedersen CB, Olsen J, Sidenius P. Incidence and prevalence of epilepsy in Denmark. Epilepsy Res. 2007;76:60-65.

    PubMed  Google Scholar 

  60. McHugh JC, Delanty N. Epidemiology and classification of epilepsy: gender comparisons. Int Rev Neurobiol. 2008;83:11-26.

    PubMed  Google Scholar 

  61. van Merode T, de Krom MC, Knottnerus JA. Gender-related differences in non-epileptic attacks: a study of patients’ cases in the literature. Seizure. 1997;6(4):311-316.

    PubMed  Google Scholar 

  62. Pennell PB, Thompson P. Gender-specific psychosocial impact of living with epilepsy. Epilepsy Behav. 2009;15:S20-S25.

    PubMed  Google Scholar 

  63. Herzog AG. Disorders of reproduction in patients with epilepsy: primary neurological mechanisms. Seizure. 2008; 17:101-110.

    PubMed  Google Scholar 

  64. Herzog AG, Harden CL, Liporace J, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol. 2004;56:431-434.

    PubMed  Google Scholar 

  65. Morrell MJ. Epilepsy in women: the science of why it is special. Neurology. 1999;53:S42-S48.

    PubMed  CAS  Google Scholar 

  66. Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia. 2006;47:1447-1451.

    PubMed  CAS  Google Scholar 

  67. Tan M, Tan U. Sex difference in susceptibility to epileptic seizures in rats: importance of estrous cycle. Int J Neurosci. 2001;108:175-191.

    PubMed  CAS  Google Scholar 

  68. Janszky J, Schulz R, Janszky I, Ebner A. Medial temporal lobe epilepsy: gender differences. J Neurol Neurosurg Psychiatry. 2004;75:773-775.

    PubMed  CAS  Google Scholar 

  69. Falip M et al. Classic antiepileptic and new generation antiepileptic drugs: gender differences in effectiveness and adverse drug reactions. Neurologia. 2005;20:71-76.

    PubMed  CAS  Google Scholar 

  70. Harden CL. Issues for mature women with epilepsy. Int Rev Neurobiol. 2008;83:385-395.

    PubMed  Google Scholar 

  71. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use. Epilepsia. 1998;39:1083-1087.

    PubMed  CAS  Google Scholar 

  72. Pita Calandre E. Adverse reactions and interactions of antiepileptic drugs in epileptic women. Rev Neurol. 2002;34:466-470.

    PubMed  CAS  Google Scholar 

  73. Mazziotti G, Canalis E, Giustina A. Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med. 2010;123:877-884.

    PubMed  CAS  Google Scholar 

  74. Hitiris N, Suratman S, Kelly K, Stephen LJ, Sills GJ, Brodie MJ. Sudden unexpected death in epilepsy: a search for risk factors. Epilepsy Behav. 2007;10:138-141.

    PubMed  Google Scholar 

  75. Kumlien E. Treatment outcome in patients with mesial temporal sclerosis. Seizure. 2002;11:413-417.

    PubMed  Google Scholar 

  76. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S4-S9.

    PubMed  CAS  Google Scholar 

  77. Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol. 2005;15:463-471.

    PubMed  CAS  Google Scholar 

  78. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003;74:1206-1209.

    PubMed  CAS  Google Scholar 

  79. Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S10-S15.

    PubMed  CAS  Google Scholar 

  80. Alvarez-de-la-Rosa M et al. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer’s disease. Ann N Y Acad Sci. 2005;1052:210-224.

    PubMed  CAS  Google Scholar 

  81. Lloret A, Badía MC, Mora NJ, et al. Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer’s disease. Free Radic Biol Med. 2008;44:2019-2025.

    PubMed  CAS  Google Scholar 

  82. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685-691.

    PubMed  Google Scholar 

  83. Barnes LL, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Gender, cognitive decline, and risk of AD in older persons. Neurology. 2003;60:1777-1781.

    PubMed  CAS  Google Scholar 

  84. Ott BR, Tate CA, Gordon NM, Heindel WC. Gender differences in the behavioral manifestations of Alzheimer’s disease. J Am Geriatr Soc. 1996;44:583-587.

    PubMed  CAS  Google Scholar 

  85. Schmidt R, Kienbacher E, Benke T, et al. Sex differences in Alzheimer’s disease. Neuropsychiatr. 2008;22:1-15.

    PubMed  Google Scholar 

  86. Cohen D, Eisdorfer C, Gorelick P, et al. Sex differences in the psychiatric manifestations of Alzheimer’s disease. J Am Geriatr Soc. 1993;41:229-232.

    PubMed  CAS  Google Scholar 

  87. Buchanan RJ, Wang S, Ju H, Graber D. Analyses of gender differences in profiles of nursing home residents with Alzheimer’s disease. Gend Med. 2004;1:48-59.

    PubMed  Google Scholar 

  88. Huang F, Fu Y. A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease, in healthy subjects and patients. Curr Clin Pharmacol. 2010;5:115-124.

    PubMed  CAS  Google Scholar 

  89. Hernandez S, McClendon MJ, Zhou XH, Sachs M, Lerner AJ. Pharmacological treatment of Alzheimer’s disease: effect of race and demographic variables. J Alzheimers Dis. 2010;19:665-672.

    PubMed  CAS  Google Scholar 

  90. Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson’s disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Italian longitudinal study on aging. Neurology. 2000;55:1358-1363.

    PubMed  CAS  Google Scholar 

  91. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology. 1999;52:1214-1220.

    PubMed  CAS  Google Scholar 

  92. Alves G, Müller B, Herlofson K, et al. Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry. 2009;80:851-857.

    PubMed  CAS  Google Scholar 

  93. Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry. 2004;75:637-639.

    PubMed  CAS  Google Scholar 

  94. Taylor KS, Cook JA, Counsell CE. Heterogeneity in male to female risk for Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78:905-906.

    PubMed  CAS  Google Scholar 

  95. Mayeux R et al. The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993. Am J Epidemiol. 1995;142:820-827.

    PubMed  CAS  Google Scholar 

  96. Haaxma CA et al. Gender differences in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78:819-824.

    PubMed  Google Scholar 

  97. Diem-Zangerl A, Seppi K, Wenning GK, et al. Mortality in Parkinson’s disease: a 20-year follow-up study. Mov Disord. 2009;24:819-825.

    PubMed  Google Scholar 

  98. Ragonese P, D’Amelio M, Salemi G, et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology. 2004;62:2010-2014.

    PubMed  CAS  Google Scholar 

  99. Popat RA, Van Den Eeden SK, Tanner CM, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology. 2005;65:383-390.

    PubMed  CAS  Google Scholar 

  100. Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol. 2004;61:886-888.

    PubMed  Google Scholar 

  101. Fernandez HH, Lapane KL, Ott BR, Friedman JH. Gender differences in the frequency and treatment of behavior problems in Parkinson’s disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology. Mov Disord. 2000;15:490-496.

    PubMed  CAS  Google Scholar 

  102. Cantuti-Castelvetri I et al. Effects of gender on nigral gene expression and Parkinson disease. Neurobiol Dis. 2007;26:606-614.

    PubMed  CAS  Google Scholar 

  103. Zeller EA et al. Molecular biology of neurological and psychiatric disorders. I. Effect of parkinsonism, age, sex and L-dopa on platelet monoamine oxidase. J Neural Transm. 1976;39:63-77.

    PubMed  CAS  Google Scholar 

  104. Lyons KE, Hubble JP, Troster AI, Pahwa R, Koller WC. Gender differences in Parkinson’s disease. Clin Neuropharmacol. 1998;21:118-121.

    PubMed  CAS  Google Scholar 

  105. Nazem S, Siderowf AD, Duda JE, et al. Montreal cognitive assessment performance in patients with Parkinson’s disease with “normal” global cognition according to mini-mental state examination score. J Am Geriatr Soc. 2009;57:304-308.

    PubMed  Google Scholar 

  106. Shulman LM. Gender differences in Parkinson’s disease. Gend Med. 2007;4:8-18.

    PubMed  Google Scholar 

  107. Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM. Gender differences in Parkinson’s disease symptom profile. Acta Neurol Scand. 2000;102:37-43.

    PubMed  CAS  Google Scholar 

  108. Biglan KM, Holloway RG Jr, McDermott MP, Richard IH, Parkinson Study Group CALM-PD Investigators. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007;69:187-195.

    PubMed  Google Scholar 

  109. Zappia M, Annesi G, Nicoletti G, et al. Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch Neurol. 2005;62:601-605.

    PubMed  Google Scholar 

  110. Accolla E et al. Gender differences in patients with Parkinson’s disease treated with subthalamic deep brain stimulation. Mov Disord. 2007;22:1150-1156.

    PubMed  Google Scholar 

  111. Kompoliti K, Comella CL, Jaglin JA, Leurgans S, Raman R, Goetz CG. Menstrual-related changes in motoric function in women with Parkinson’s disease. Neurology. 2000;55:1572-1575.

    PubMed  CAS  Google Scholar 

  112. Arabia G et al. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson’s disease. Neurol Sci. 2002;23: S53-S54.

    PubMed  Google Scholar 

  113. Zappia M et al. Body weight influences pharmacokinetics of levodopa in Parkinson’s disease. Clin Neuropharmacol. 2002;25:79-82.

    PubMed  CAS  Google Scholar 

  114. Hariz GM, Hariz I. Gender distribution in surgery for Parkinson’s disease. Parkinsonism Relat Disord. 2000;6:155-157.

    PubMed  Google Scholar 

  115. Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR, Study of Osteoporotic Fractures (SOF) Research Group. The association of Parkinson’s disease with bone mineral density and fracture in older women. Osteoporos Int. 2008;19:1093-1097.

    PubMed  CAS  Google Scholar 

  116. Hariz GM, Lindberg M, Hariz MI, Bergenheim AT. Gender differences in disability and health-related quality of life in patients with Parkinson’s disease treated with stereotactic surgery. Acta Neurol Scand. 2003;108:28-37.

    PubMed  Google Scholar 

  117. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry. 2000;69:308-312.

    PubMed  CAS  Google Scholar 

  118. Freye C. Hormonal Influences on Seizures: Basic Neurobiology. Int Review of Neurobiology (2008) 83:27-77. J Neurol Neurosurg Psychiatry. 2000;69:308-312.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Charité University Medicine, Berlin, Germany

    Christian H. Nolte

  2. Center for Stroke Research Berlin, Charité University Medicine, Berlin, Germany

    Peter U. Heuschmann

  3. Department of Neurology and Center for Stroke Research Berlin, Charité University Medicine, Berlin, Germany

    Matthias Endres

Authors
  1. Christian H. Nolte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter U. Heuschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthias Endres
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian H. Nolte .

Editor information

Editors and Affiliations

  1. Charite´- Universitätsmedizin Berlin, Institute of Gender in Medicine (GiM), Berlin, 10115, Germany

    Sabine Oertelt-Prigione

  2. Inst. Geschlechterforschung in der, Medizin, Charité - Universitätsmedizin Berlin, Hessische Str. 3-4, Berlin, 10115, Germany

    Vera Regitz-Zagrosek

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

Nolte, C.H., Heuschmann, P.U., Endres, M. (2012). Sex and Gender Differences in Neurology. In: Oertelt-Prigione, S., Regitz-Zagrosek, V. (eds) Sex and Gender Aspects in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-0-85729-832-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-832-4_11

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-831-7

  • Online ISBN: 978-0-85729-832-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation